Tenax Therapeutics Inc/ US88032L6056 /
15.11.2024 22:00:00 | Изменение -0.0700 | Объем сделки | Бид1:55:44 | Предложение1:55:44 | Максимум | Минимум |
---|---|---|---|---|---|---|
4.8700USD | -1.42% | 44,852 Оборот: 197,847.3316 |
4.7500Величина цены спроса: 100 | 5.0000Величина цены предложения: 300 | 5.0000 | 4.8600 |
GlobeNewswire
13.08
Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
12.08
Tenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the O...
GlobeNewswire
14.05
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
30.04
Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertens...
GlobeNewswire
09.04
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a...
GlobeNewswire
28.03
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial ...
GlobeNewswire
29.02
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT ...
GlobeNewswire
20.02
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimen...
GlobeNewswire
08.02
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
GlobeNewswire
08.02
Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimenda...
GlobeNewswire
06.02
Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significa...
GlobeNewswire
17.11.2023
Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific ...
GlobeNewswire
13.11.2023
Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment ...
GlobeNewswire
04.01.2022
Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs
- Первая страница
- Назад
- 1
- 2
- Следующий
- Последняя страница